1. Home
  2. PDYNW vs HUMAW Comparison

PDYNW vs HUMAW Comparison

Compare PDYNW & HUMAW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Palladyne AI Corp

PDYNW

Palladyne AI Corp

HOLD

Current Price

$0.08

Market Cap

0.0

Sector

Industrials

ML Signal

HOLD

Logo Humacyte Inc. Warrant

HUMAW

Humacyte Inc. Warrant

N/A

Current Price

$0.15

Market Cap

0.0

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
PDYNW
HUMAW
Founded
2017
2004
Country
United States
United States
Employees
70
220
Industry
Wholesale Distributors
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
N/A
N/A
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
PDYNW
HUMAW
Price
$0.08
$0.15
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
210.9K
14.2K
Earning Date
02-28-2025
03-21-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$7,771,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.11
$1.18
52 Week High
$0.54
$1.34

Technical Indicators

Market Signals
Indicator
PDYNW
HUMAW
Relative Strength Index (RSI) 35.13 44.95
Support Level $0.08 $0.11
Resistance Level $0.09 $0.15
Average True Range (ATR) 0.02 0.03
MACD 0.00 0.00
Stochastic Oscillator 14.81 91.78

Price Performance

Historical Comparison
PDYNW
HUMAW

About PDYNW Palladyne AI Corp

Palladyne AI Corp is a software company focused on autonomy for robotic systems and solutions. Its artificial intelligence and machine learning software seeks to revolutionize the capabilities of robots, enabling them to observe, learn, reason, and act in structured and unstructured environments. AI and ML software platform of the company empowers robots to perceive variations or changes in the real-world environment, enabling them to autonomously maneuver and manipulate objects accurately in response. Palladyne AI software has wide application, including in industries such as automotive, aviation, construction, defense, general manufacturing, infrastructure inspection, logistics and warehousing.

About HUMAW Humacyte Inc. Warrant

Humacyte Inc is developing a disruptive biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine. It develops and manufactures acellular tissues to treat a wide range of diseases, injuries, and chronic conditions. Company's pipeline includes Vascular Trauma, PAD, Dailysis, Acellular Tissue Engineered Vessels, Organ Systems, Advanced Tissue Constructs.

Share on Social Networks: